NASDAQ IMMY

Andrew R. Boll, CFA, CMA

Chief Financial Officer

Mr. Boll is one of our founding employees at Imprimis. As our Chief Financial Officer and Corporate Secretary, he oversees the Company’s financial and administrative operations including its accounting, financial reporting, investor relations, human resources, legal and other administrative departments. Mr. Boll has been integral in the evolution of Imprimis, as a leader during the company’s initial start-up stage, to its NASDAQ listing, M&A activities and current commercial stage. Mr. Boll is also a founder of Eton Pharmaceuticals, Surface Pharmaceuticals, and Melt Pharmaceuticals, and serves on the board of Melt. Prior to Imprimis, from 2007 to 2011, Mr. Boll worked for an investment company where he oversaw the fund’s accounting, financial analysis, and reporting; he was also heavily involved with the financial operations of a number of the fund’s portfolio companies (public and private). Prior to 2007, Mr. Boll held various accounting roles at Welsh Companies, LLC, a commercial real estate company, its fund and its other subsidiaries. Mr. Boll is a CFA charter holder, Certified Management Accountant and earned his Bachelor of Science degree, summa cum laude, in Corporate and Public Finance.


Stay Connected

Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745

Contact Us Today

 

Stay Informed

Interested in receiving investor news and updates?

Click Here


Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.